Baker Ellis Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Sell
6,615
-390
-6% -$103K 0.19% 89
2026
Q1
$1.87M Hold
7,005
0.22% 85
2025
Q4
$1.76M Sell
7,005
-300
-4% -$79.7K 0.21% 81
2025
Q3
$2.1M Sell
7,305
-50
-0.7% -$13.4K 0.26% 78
2025
Q2
$1.93M Sell
7,355
-580
-7% -$141K 0.27% 75
2025
Q1
$1.85M Buy
7,935
+90
+1% +$21.8K 0.27% 77
2024
Q4
$1.8M Sell
7,845
-294
-4% -$67.4K 0.26% 77
2024
Q3
$1.82M Sell
8,139
-242
-3% -$53.2K 0.26% 80
2024
Q2
$1.71M Sell
8,381
-465
-5% -$94.6K 0.26% 80
2024
Q1
$1.93M Buy
8,846
+280
+3% +$61.7K 0.29% 80
2023
Q4
$1.95M Sell
8,566
-13,518
-61% -$2.84M 0.31% 78
2023
Q3
$4.44M Sell
22,084
-3,723
-14% -$785K 0.8% 42
2023
Q2
$5.35M Sell
25,807
-640
-2% -$124K 0.91% 35
2023
Q1
$5.21M Buy
26,447
+449
+2% +$92.4K 0.93% 35
2022
Q4
$5.26M Buy
25,998
+425
+2% +$83.1K 1.02% 32
2022
Q3
$4.5M Sell
25,573
-82
-0.3% -$16.8K 0.98% 32
2022
Q2
$5.17M Sell
25,655
-150
-0.6% -$32K 1.07% 27
2022
Q1
$5.84M Buy
25,805
+734
+3% +$173K 1.05% 26
2021
Q4
$6.77M Buy
25,071
+114
+0.5% +$28.2K 1.19% 21
2021
Q3
$5.87M Sell
24,957
-1,141
-4% -$288K 1.13% 23
2021
Q2
$6.18M Buy
26,098
+1,043
+4% +$238K 1.21% 17
2021
Q1
$5.49M Buy
25,055
+1,917
+8% +$385K 1.19% 22
2020
Q4
$4.05M Buy
23,138
+260
+1% +$44.9K 0.97% 31
2020
Q3
$3.7M Buy
22,878
+434
+2% +$68.8K 1.03% 30
2020
Q2
$3.2M Buy
22,444
+932
+4% +$129K 0.94% 30
2020
Q1
$2.34M Buy
21,512
+2,540
+13% +$366K 0.84% 31
2019
Q4
$2.76M Sell
18,972
-396
-2% -$57.2K 0.76% 36
2019
Q3
$2.79M Sell
19,368
-302
-2% -$44.1K 0.74% 36
2019
Q2
$2.92M Buy
19,670
+1,118
+6% +$156K 0.78% 36
2019
Q1
$2.44M Buy
18,552
+388
+2% +$47.8K 0.68% 43
2018
Q4
$1.97M Sell
18,164
-1,118
-6% -$150K 0.6% 46
2018
Q3
$2.88M Buy
19,282
+8,614
+81% +$1.31M 0.74% 37
2018
Q2
$1.65M Buy
10,668
+3,044
+40% +$459K 0.43% 72
2018
Q1
$1.06M Hold
7,624
0.28% 92
2017
Q4
$1.04M Hold
7,624
0.26% 91
2017
Q3
$989K Sell
7,624
-58
-0.8% -$7.74K 0.26% 96
2017
Q2
$1.02M Hold
7,682
0.28% 94
2017
Q1
$947K Sell
7,682
-35
-0.5% -$4.14K 0.27% 101
2016
Q4
$851K Buy
7,717
+116
+2% +$12.9K 0.25% 104
2016
Q3
$898K Hold
7,601
0.27% 96
2016
Q2
$851K Buy
7,601
+116
+2% +$12.5K 0.27% 93
2016
Q1
$753K Buy
7,485
+373
+5% +$35.8K 0.25% 98
2015
Q4
$755K Buy
7,112
+466
+7% +$48.1K 0.26% 94
2015
Q3
$619K Sell
6,646
-59
-0.9% -$6.1K 0.22% 108
2015
Q2
$698K Buy
6,705
+384
+6% +$40K 0.23% 103
2015
Q1
$685K Buy
6,321
+1,432
+29% +$147K 0.22% 107
2014
Q4
$453K Buy
4,889
+233
+5% +$20.6K 0.15% 126
2014
Q3
$407K Sell
4,656
-116
-2% -$10.5K 0.14% 138
2014
Q2
$420K Buy
4,772
+116
+2% +$10K 0.14% 142
2014
Q1
$393K Hold
4,656
0.14% 142
2013
Q4
$365K Buy
4,656
+233
+5% +$19.9K 0.13% 154
2013
Q3
$377K Buy
4,423
+116
+3% +$9.77K 0.14% 142
2013
Q2
$370K Buy
+4,307
New +$358K 0.15% 136

Other funds holding LH

Baker Ellis Asset Management's LH Position: Q2 2026 in Review

Baker Ellis Asset Management reduced its Labcorp (LH) stake by 5.6% in Q2 2026, selling an estimated $103K and leaving 6,615 shares worth $1.85M. The position accounts for 0.19% of the portfolio, ranked #89.

Baker Ellis Asset Management first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.77M in Q4 2021. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Baker Ellis Asset Management held 6,615 shares of Labcorp worth $1.85M as of Q2 2026.
  • Baker Ellis Asset Management sold 390 Labcorp shares in Q2 2026, an estimated $103K.
  • Labcorp made up 0.19% of Baker Ellis Asset Management's portfolio in Q2 2026, its #89 holding.
  • Baker Ellis Asset Management first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • Baker Ellis Asset Management's Labcorp position peaked at $6.77M in Q4 2021.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.